Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start

Go back to Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 200.36 --0 (-0%)
Previous Close $200.36    52 Week High $333.65 
Open $200.36    52 Week Low $223.02 
Day High $200.36    P/E 25.65 
Day Low $200.36    EPS $7.81 
Volume 140